Views

CrossRef citations to date

Altmetric

LETTERS TO THE EDITOR: MEDICAL ONCOLOGY

Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy

Ji-Nuo WangDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

http://orcid.org/0000-0003-4036-7547 View further author information

Yu QiuDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; View further author information

Na NiuDepartment of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaView further author information

Yan ZhangDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

http://orcid.org/0000-0003-0244-218X View further author information

Jian LiDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;

http://orcid.org/0000-0002-4549-0694 View further author information

Dao-bin ZhouDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; View further author information

Xin-Xin CaoDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Correspondence[email protected]
View further author information

show all

Click to increase image sizeClick to decrease image size

Disclosure statement

The authors report no conflicts of interest.

Additional information

Funding

This study was supported by The Nonprofit Central Research Institute Fund of Chinese Academy of Medical Sciences (2019-RC-HL-001, for CXX), The CAMS Innovation Fund for Medical Sciences (Grant No. 2016-12 M-1-002, for LJ), and The National Key Research and Development Program of China (Grant No. 2016YFC0901503, for LJ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy

Information for

Open access

Opportunities

Help and information

Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy

Disclosure statement

Additional information

Funding

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature